MRCEM Notes

Immunoglobulins (antibodies)

On this page

Production and distribution

Immunoglobulins are produced by plasma cells (differentiated B lymphocytes) in the following tissues:
  • Bone marrow
  • Lymph nodes
  • Spleen
  • Mucosa-associated lymphoid tissue (MALT) e.g. Peyer’s patches, tonsils

Once produced antibodies may be found in:
  • Serum (blood/plasma): mainly IgG, IgM
  • Mucosal secretions: IgA (coats epithelial surfaces in GI, respiratory, genitourinary tracts)
  • Bound to cells via Fc receptors (IgE on mast cells, basophils & eosinophils, IgG on macrophages, neutrophils & NK cells)
  • On B-cell surfaces: IgM and IgD act as antigen receptors

Structure
Immunoglobulins (antibodies) are composed of 2 identical heavy chains and 2 identical light chains joined by disulphide (disulfide) bonds.

Antibody structure. Click on image to enlarge

Heavy chains determine isotype: γ (IgG), α (IgA), μ (IgM), ε (IgE), δ (IgD).
Light chains are either κ (kappa) or λ (lambda).
Variable region (of heavy and light chains): gives antigen specificity.
Constant region: defines class and effector functions.
Fab region: antigen binding.
Fc region: binds complement and Fc receptors on immune cells.
Hinge region: provides flexibility.

Antibody forms:

  • IgA: monomer (serum) or dimer (secretions).
  • IgM: pentamer (serum) or monomer (B-cell receptor).
  • IgD, IgE and IgG: monomers.

Types


Class
StructureSerum %Main functions
IgGMonomer~75–80%Main antibody in secondary response; crosses placenta; opsonisation; complement activation; ADCC
IgAMonomer (serum), dimer (secretions)~15%Mucosal immunity (respiratory, GI, saliva, tears, breast milk); passive protection in infants
IgMPentamer (serum), monomer (BCR)~10%First antibody in primary response; strong complement activator; B-cell receptor (monomeric form)
IgEMonomer<1%Mast cell/basophil degranulation; allergic reactions; defence against helminths
IgDMonomer<1%Present on naïve B-cells as receptor; role largely unknown

Functions
  • Neutralisation: toxins, viruses, prevent pathogen adherence.
  • Opsonisation: tag antigens for phagocytosis.
  • Agglutination: clumping antigens for clearance.
  • Complement activation (classical pathway → lysis, opsonisation).
  • ADCC: antibody-dependent cell-mediated cytotoxicity (via NK cells, cytotoxic T cells).
  • B-cell receptor function (IgM, IgD).
  • Mucosal immunity (IgA-mediated).
  • Mast cell/basophil degranulation (IgE, also some IgG).
  • Passive immunity to newborn (IgG via placenta, IgA via breast milk).
Full-size image